insights_auto
Why is HLNCF up 2.82%?
Dive Deeperchevron_right
HLNCF:OTCMKTS
Haleon PLC
$4.52
arrow_upward
+2.82%(+0.12) 1D
Sep 28, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLNCF...
Open
$4.38
High
$4.52
Low
$4.37
Mkt. cap
39.45B
Avg. vol.
6.69K
Volume
27.88K
52-wk high
$5.75
52-wk low
$4.15
Beta
-21.89
Shares outstanding
8.80B
No. of employees
25K
Open
$4.38
High
$4.52
Low
$4.37
Mkt. cap
39.45B
Avg. vol.
6.69K
Volume
27.88K
52-wk high
$5.75
52-wk low
$4.15
Beta
-21.89
Shares outstanding
8.80B
No. of employees
25K
News stories
From web sources and news partners
AskTraders
·
6 hours ago
Haleon Shares: JPMorgan Bearish, Warns On Growing Risks
AD HOC NEWS
·
7 hours ago
Haleon stock last trades at GBp 340.20 on September 28, 2026, down 0.73 percent
Investing.com
·
15 hours ago
JPMorgan cuts Haleon stock price target on growth concerns
Profile
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
About Haleon PLC